Laurion Capital Management LP Biogen Inc. Transaction History

Laurion Capital Management LP

$7.27 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $262,556 - $312,228	-1,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $271,278 - $341,796	1,400 New	1,400 $295,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $1.05 Million - $1.68 Million	-4,039 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $292,025 - $342,125	-1,202 Reduced 22.93%	4,039 $1.13 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $1.24 Million - $1.86 Million	5,241 New	5,241 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $497,238 - $574,123	-1,878 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $12.5 Million - $16.6 Million	-48,377 Reduced 96.26%	1,878 $502,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $7.67 Million - $8.61 Million	35,292 Added 235.86%	50,255 $11.7 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $3.28 Million - $3.62 Million	14,963 New	14,963 $3.5 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $28.5 Million - $44.6 Million	-131,657 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $33.9 Million - $42.9 Million	121,651 Added 1215.78%	131,657 $39.6 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.41 Million - $1.84 Million	4,806 Added 92.42%	10,006 $3.54 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $283,272 - $337,601	1,100 Added 26.83%	5,200 $1.51 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $1.77 Million - $2.51 Million	-6,823 Reduced 62.46%	4,100 $1.12 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $4.43 Million - $4.96 Million	-14,408 Reduced 56.88%	10,923 $3.48 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $7.12 Million - $8.35 Million	25,331	25,331 $7.93 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account